Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic fatigue syndrome]

E E Trinidad1, C Ramírez-Ronda

  • 1Programa de Enfermedades Infecciosas Universidad de Puerto Rico, San Juan.

Boletin De La Asociacion Medica De Puerto Rico
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1997
Same author

Current and future management of serious skin and skin-structure infections.

The American journal of medicine·1996
Same author

Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.

The Journal of infectious diseases·1996
Same author

[Pancreatic abscess and infected pseudocyst].

Boletin de la Asociacion Medica de Puerto Rico·1994
Same author

Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.

Clinical therapeutics·1993
Same author

Treatment of urinary tract infection with norfloxacin. Analysis of cost.

The American journal of medicine·1987

Chronic Fatigue Syndrome (CFS) is a complex disease with unknown causes, affecting approximately 24% of people. Diagnosis involves excluding other conditions, and treatment is primarily supportive.

Area of Science:

  • Medical Science
  • Immunology
  • Neurology

Background:

  • Chronic Fatigue Syndrome (CFS) is a debilitating condition with a history dating back to the 18th century.
  • Its etiology remains largely unknown, presenting a significant diagnostic challenge.
  • CFS is characterized by persistent, unexplained fatigue, impacting an estimated 24% of the population.

Purpose of the Study:

  • To provide a concise overview of Chronic Fatigue Syndrome.
  • To highlight key aspects of its definition, prevalence, and diagnosis.
  • To summarize current understanding and management approaches for CFS.

Main Methods:

  • Literature review of historical and contemporary research on CFS.
  • Analysis of diagnostic criteria and epidemiological data.

Related Experiment Videos

  • Synthesis of information regarding clinical presentation and treatment.

    • Main Results:

    • CFS definition established in 1988 by expert consensus.
    • Diagnosis is often one of exclusion, requiring differentiation from similar conditions.
    • Global case reports indicate higher prevalence in women aged 20-50.

    Conclusions:

    • CFS is a recognized medical condition with significant public health implications.
    • Effective diagnostic strategies and targeted treatments are areas of ongoing research.
    • Current management focuses on supportive care to alleviate symptoms and improve quality of life.